# AEMCOLO
> **NDA210910** · New Drug Application · Sponsor: COSMO TECHNOLOGIES · Approved 2018-11-16
## Drug
- **FDA Application Number:** NDA210910
- **Application type:** New Drug Application
- **Brand name:** AEMCOLO
- **Generic name:** Rifamycin Sodium
- **Active ingredients:** RIFAMYCIN SODIUM
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** COSMO TECHNOLOGIES
- **First approval:** 2018-11-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210910)
---
*AI Analytics · CC0 1.0*